JPRN-jRCT2011210014进行中（未招募）未知
40-301 : Special Drug Use-Results Survey of ADLUMIZ (Cancer cachexia: non-small cell lung cancer, gastric cancer, pancreatic cancer, large intestine cancer)
Kuro Toshihiko0 个研究点目标入组 5,000 人开始时间: 2021年5月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 5,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •All patients with (Cancer cachexia: non-small cell lung cancer, gastric cancer, pancreatic cancer, large intestine cancer) for whom ADLUMIZ is administered
排除标准
- •patients who have not received ADLUMIZ
研究者
相似试验
进行中（未招募）
不适用
43-301 : Special Drug Use-Results Survey of ONGENTYSParkinson's diseaseJPRN-jRCT2011210013Kuro Toshihiko250
已完成
不适用
A Study of TAK-660 in surgical procedures for people with hemophilia AHemophilia AJPRN-jRCT2031210173Contact for Clinical Trial Information17
已完成
不适用
Special Drug Use-results Survey for Long-term Administration of Tramcet Combination TabletsChronic painJPRN-UMIN000015901Janssen Pharmaceutical K.K.1,200
已完成
不适用
Special Drug Use-results Survey for Long-term Administration of Durotep MT Patch 2.1mg/ 4.2mg/ 8.4mg/ 12.6mg/ 16.8mgChronic painJPRN-UMIN000015898Janssen Pharmaceutical K.K.500
已完成
不适用
Special Drug Use-results Survey for Long-term Administration of Invega 3mg/6mg/9mg TabletSchizophreniaJPRN-UMIN000015599Janssen Pharmaceutical K.K.1,350